A Study On New Vertical Growth Opportunities For Continuous Glucose Monitoring Devices

Continuous Glucose Monitoring (CGM) Devices - Penetration into Athletics

Originally, continuous glucose monitoring (CGM) devices were intended for diabetes management in chronic patients. The entry of CGM outside the diabetic population started with endurance athletes using CGM to assess the impact of different practicing methods and diets on their performances. A notable example includes the national football league (NFL) using CGM devices on its players to ensure appropriate treatment with the help of blood glucose readings. Nowadays, CGMs are marketed for common fitness enthusiasts. 

We are working on a special report on over-the-counter (OTC) CGM devices used in non-diabetes applications and their impact on the overall blood glucose monitoring device market.

Currently, the major brands marketing their CGM devices in athletics include Abbott (Libre Sense), Nutrisense, Levels, and Supersapiens. Recently a digital health and wellness company (HealthifyMe) in India started providing CGM devices to their Pro subscribers. The sensors of these devices are sourced from Abbott’s Freestyle Libre. 

The data availability for effective decision-making in athletics based on the CGM reading is not sufficient. The report highlights the outlook on the mammoth opportunities for CGM manufacturers and analytics service providers. The report focuses on current and future scenarios that would impact the application of continuous glucose monitoring devices in diabetic patients and fitness enthusiasts.  

Vertical Growth Opportunities for CGM Devices Report Scope